As a cell surface receptor, RAGE is widely expressed on both tumor and immune cells and recognizes multiple secretory substrates, including HMGB1 and S100 proteins, triggering downstream inflammation-related signaling cascades [150–152]. Here, AGER is linked to neoplasm.